Craig Bijou
Stock Analyst at B of A Securities
(3.85)
# 611
Out of 4,884 analysts
62
Total ratings
64.71%
Success rate
61.3%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $57.92 | +45.03% | 4 | Apr 25, 2025 | |
| RXST RxSight | Maintains: Buy | $60 → $36 | $13.05 | +175.86% | 1 | Mar 21, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $119.90 | +16.76% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $13.88 | +22.48% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $59.17 | +63.93% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $13.49 | +33.43% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $121.00 | +19.83% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $93.58 | +10.07% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $76.87 | +10.58% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $76.07 | +13.05% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $73.30 | +29.60% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $18.47 | +94.91% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.80 | +561.76% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $3.28 | +3,558.54% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $6.11 | +391.00% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $13.24 | -1.81% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $11.12 | +277.70% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $544.47 | -57.76% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $395.28 | -41.81% | 4 | Jul 26, 2019 |
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $57.92
Upside: +45.03%
RxSight
Mar 21, 2025
Maintains: Buy
Price Target: $60 → $36
Current: $13.05
Upside: +175.86%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $119.90
Upside: +16.76%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $13.88
Upside: +22.48%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $59.17
Upside: +63.93%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $13.49
Upside: +33.43%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $121.00
Upside: +19.83%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $93.58
Upside: +10.07%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $76.87
Upside: +10.58%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $76.07
Upside: +13.05%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $73.30
Upside: +29.60%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $18.47
Upside: +94.91%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.80
Upside: +561.76%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $3.28
Upside: +3,558.54%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $6.11
Upside: +391.00%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $13.24
Upside: -1.81%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $11.12
Upside: +277.70%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $544.47
Upside: -57.76%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $395.28
Upside: -41.81%